CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Plasmacure has developed PLASOMA, a medical device utilizing atmospheric cold plasma to treat chronic wounds. This innovative technology aims to significantly improve healing outcomes, reduce healthcare costs, and enhance patients' quality of life by effectively addressing wounds that are currently difficult to heal.
Plasmacure has been established in 2014 and currently employs 12 people.
We have our own test facilities and technical staff.
In 2018, we have received an A-round Investment of €2.2 million.
Our mission statement is:
We envision a world where people no longer suffer from chronic wounds.
In Europe, > 3 million people suffer from this condition.
Chronic wounds cause pain, lead to amputations and loss of independence.
Average costs are € 12,000 per wound.
Currently, 25% of these wounds persist for…
PLASMACURE BV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
